VTYX — VENTYX BIOSCIENC

Ownership history in MARSHALL WACE, LLP  ·  7 quarters on record

This page tracks every 13F SEC filing in which MARSHALL WACE, LLP reported a position in VENTYX BIOSCIENC (VTYX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.03% (2023 Q1)
Avg. % of fund
0.01%
First filed
2023 Q1
Last filed
2025 Q3
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 2,316,275 -80,548 -3.4% 0.01% $7.2M $3.11
2025 Q2 ADDED 2,396,823 +2,218,309 +1242.7% 0.01% $5.1M $2.14
2024 Q3 REDUCED 178,514 -344,345 -65.9% 0.00% $389K $2.18
2023 Q4 ADDED 522,859 +188,121 +56.2% 0.00% $1.3M $2.47
2023 Q3 ADDED 334,738 +94,738 +39.5% 0.02% $11.6M $34.73
2023 Q2 REDUCED 240,000 -198,658 -45.3% 0.02% $7.9M $32.80
2023 Q1 INITIATED 438,658 — — 0.03% $14.7M $33.50
% of Fund (quarterly)    VTYX price (monthly, adj. close)

Other funds also holding VTYX

As of 2025 Q4 — sorted by position size

Affinity Asset Advisors, LLC 3Y 3.34% Lion Point Capital, LP 3Y 7Y 1.94% MPM BioImpact LLC 3Y 1.69% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 1.26% Artia Global Partners LP 3Y 0.89% SECTORAL ASSET MANAGEMENT INC 3Y 7Y 0.7% Ikarian Capital, LLC 3Y 0.68% BRAIDWELL LP 3Y 0.55% Sio Capital Management, LLC 3Y 7Y 0.55% Birchview Capital, LP 3Y 7Y 0.53%
← Back to MARSHALL WACE, LLP Holdings